leisure time -WSS

leisure time

author：focus 2025-09-27 16:48:53 - browse：5

A person wears five fitness tracking watches on their wrist — first opinion coverage from STAT — Bebeto Matthews/AP

Turn on your TV or open a web browser this January, and you’ll be bombarded with ads for fitness trackers, smart scales, health apps, and other digital innovations promising to streamline your journey to a happier and healthier you. It’s the time of year when we’re most susceptible to such messaging: Surveys show that at least one-third of our New Year’s resolutions focus on exercising, losing weight, or eating better.

That’s great news for the $45 billion fitness tracking industry, which spends vast sums on advertising designed to convince us that data is the key to better living. The marketing campaigns work: Each January, fitness app downloads spike 36% higher than usual. We’ve also seen the rise of over 400 personalized nutrition companies, while over 12 million people have sequenced their DNA through 23andMe.

Only one problem: The data isn’t working. At least 1.4 million Americans are diagnosed with diabetes each year. Obesity rates soared from 31% to 42% over the past decade. Life expectancy is declining. We were told data would put us in control, but we’re actually less healthy than ever.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Neuroscience’s long legacy of racism

explore

WSS

Creating egg and sperm cells from stem cells raises ethical issues

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

SCOTUS questions limit to govt efforts to fight misinformation

Health AI adoption puts security, privacy startups on investors' radar

Gene editing the human germline: What are the risks?

How state and local governments are sidelining science

knowledge

leisure time

leisure time

Medicare proposal to cover medical devices draws a mixed reaction

Physicians and social media: If you see something, say something?

Walensky prepares to leave CDC — and Congress — behind

App could help diagnose ear infections more accurately — and at home

The cancer drug shortage isn’t new — and neither are the solutions

Today's health inequities arise from racist U.S. history, say experts

Continuity nursing helped my family in our darkest PICU moments

Experimental asthma app from Apple and Anthem shows promise

United colonoscopy coverage change 'may cost lives,' doctors say

AstraZeneca to buy developer of next

focus

U.K. researchers warn about biases in medical devices, algorithms

After decades in use, heart stents finally beat placebo

Creating egg and sperm cells from stem cells raises ethical issues

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Leading voice in opioid treatment defends methadone clinic system

NIH chief: government has fallen behind pharma on clinical trials

explore

explore

focus

hotspot